Titan Pharmaceuticals
(NASDAQ) TTNP
Titan Pharmaceuticals Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$10.00K
Net Income (TTM)
$2.85M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
TTNP News
TTNP: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Titan Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
4
CEO
Weei Jye Chay
Website
www.titanpharm.comHeadquarters
Petaling Jaya, KY
TTNP Financials
Key Financial Metrics (TTM)
Gross Margin
33%
Operating Margin
8%
Net Income Margin
8%
Return on Equity
0%
Return on Capital
0%
Return on Assets
0%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$5.00K
Operating Income
$4.56M
EBITDA
$4.70M
Operating Cash Flow
$3.88M
Capital Expenditure
$0.00
Free Cash Flow
$3.88M
Cash & ST Invst.
$2.83M
Total Debt
$0.00
Titan Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
4
N/A
Net Income
$803.00K
-5.2%
EBITDA
$803.00K
-6.5%
Quarterly Fundamentals
Net Cash
$1.96M
-42.5%
Accounts Receivable
$232.00K
+346.2%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
0.00%
N/A
Return on Invested Capital
0.00%
N/A
Free Cash Flow
$759.00K
-9.5%
Operating Cash Flow
$754.00K
-8.8%